EA201290373A1 - Синергическая противовирусная композиция и ее применение - Google Patents

Синергическая противовирусная композиция и ее применение

Info

Publication number
EA201290373A1
EA201290373A1 EA201290373A EA201290373A EA201290373A1 EA 201290373 A1 EA201290373 A1 EA 201290373A1 EA 201290373 A EA201290373 A EA 201290373A EA 201290373 A EA201290373 A EA 201290373A EA 201290373 A1 EA201290373 A1 EA 201290373A1
Authority
EA
Eurasian Patent Office
Prior art keywords
application
synergistic anti
virus composition
virus
iota
Prior art date
Application number
EA201290373A
Other languages
English (en)
Other versions
EA022840B1 (ru
Inventor
Андреас Грассауэр
Ева Пришл-Грассауэр
Кристиане Майер
Мариэлле Кениг-Шустер
Original Assignee
Мариномед Биотехнологи Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44063696&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201290373(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Мариномед Биотехнологи Гмбх filed Critical Мариномед Биотехнологи Гмбх
Publication of EA201290373A1 publication Critical patent/EA201290373A1/ru
Publication of EA022840B1 publication Critical patent/EA022840B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к йота- и/или каппа-каррагинану в комбинации с ингибитором нейраминидазы для применения в качестве медикамента при профилактическом или терапевтическом воздействии на симптом, состояние или заболевание, вызываемые или связанные с инфекцией вируса гриппа.
EA201290373A 2009-12-22 2010-12-17 Фармацевтическая композиция, набор, их применение и способ профилактики и лечения симптома, состояния или заболевания, связанного с инфекцией вируса гриппа EA022840B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28214809P 2009-12-22 2009-12-22
PCT/EP2010/007726 WO2011076367A2 (en) 2009-12-22 2010-12-17 Synergistic antiviral composition and use thereof

Publications (2)

Publication Number Publication Date
EA201290373A1 true EA201290373A1 (ru) 2012-11-30
EA022840B1 EA022840B1 (ru) 2016-03-31

Family

ID=44063696

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201290373A EA022840B1 (ru) 2009-12-22 2010-12-17 Фармацевтическая композиция, набор, их применение и способ профилактики и лечения симптома, состояния или заболевания, связанного с инфекцией вируса гриппа

Country Status (21)

Country Link
US (1) US10022449B2 (ru)
EP (1) EP2515889B1 (ru)
JP (1) JP5902628B2 (ru)
KR (1) KR101862415B1 (ru)
CN (1) CN102652017A (ru)
AU (1) AU2010335594B2 (ru)
BR (1) BR112012015202B1 (ru)
CA (1) CA2779532C (ru)
CL (1) CL2012001695A1 (ru)
DK (1) DK2515889T3 (ru)
EA (1) EA022840B1 (ru)
ES (1) ES2531367T3 (ru)
IL (1) IL219552A (ru)
MX (1) MX2012007166A (ru)
NZ (1) NZ599839A (ru)
PL (1) PL2515889T3 (ru)
PT (1) PT2515889E (ru)
SG (1) SG181421A1 (ru)
SI (1) SI2515889T1 (ru)
WO (1) WO2011076367A2 (ru)
ZA (1) ZA201202482B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012126777A1 (en) * 2011-03-18 2012-09-27 Marinomed Biotechnologie Gmbh Inhibition of neuraminidase activity
RU2469020C1 (ru) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения
RU2520836C1 (ru) * 2013-02-27 2014-06-27 Александр Васильевич Иващенко (3r,4r,5s)-4-амино-5-(2,2-дифторацетиламино)-3-(1-этилпропокси)-циклогекс-1-енкарбоновая кислота и ее эфиры, способ их получения и применения
EP2898888B8 (en) * 2014-01-22 2019-06-12 VISUfarma B.V. Composition comprising iota-carrageenan against viral Conjunctivitis
CN117942405A (zh) * 2016-02-25 2024-04-30 应用生物实验室公司 保护空气传播的病原体和刺激物的组合物和方法
US11304989B2 (en) * 2017-10-06 2022-04-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Peptides for use in the treatment of viral infections
WO2019160261A1 (ko) * 2018-02-14 2019-08-22 (주)나노메디카 항바이러스 처리 방법, 항바이러스 필터, 및 이를 구비한 마스크
KR102316819B1 (ko) * 2018-04-20 2021-10-25 한미약품 주식회사 카라기난을 유효성분으로 포함하는 보존성이 개선된 액상 제제
EP3995149A4 (en) * 2019-07-03 2023-07-19 Allis Inc. PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLUENCE VIRUS INFECTIONS
WO2021184123A1 (en) * 2020-03-18 2021-09-23 Encyt Technologies, Inc. Compositions and methods for the treatment of coronavirus infection and respiratory compromise

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593314B1 (en) * 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
JP2001181188A (ja) * 1999-12-28 2001-07-03 Marine Biotechnol Inst Co Ltd インフルエンザウイルス感染阻害剤
KR101437708B1 (ko) 2006-12-05 2014-09-03 마리노메드 바이오테크놀로지 게엠베하 항바이러스 조성물과 이의 이용 방법
EP1930015A1 (en) * 2006-12-05 2008-06-11 Marinomed Biotechnologie GmbH Use of carrageenan for treating rhinovirus infections
CA2673313A1 (en) 2006-12-18 2008-12-04 Amcol International Virus-interacting layered phyllosilicates and methods of use
UA102673C2 (ru) * 2007-08-24 2013-08-12 Мариномед Биотехнологи Гмбх Применение йота-каррагенана как противовирусного активного ингредиента

Also Published As

Publication number Publication date
NZ599839A (en) 2014-02-28
EP2515889A2 (en) 2012-10-31
JP2013515022A (ja) 2013-05-02
CN102652017A (zh) 2012-08-29
AU2010335594A1 (en) 2012-05-24
SI2515889T1 (sl) 2015-04-30
ES2531367T3 (es) 2015-03-13
MX2012007166A (es) 2012-07-23
ZA201202482B (en) 2012-12-27
SG181421A1 (en) 2012-07-30
AU2010335594B2 (en) 2015-05-21
CA2779532C (en) 2018-05-22
BR112012015202A2 (pt) 2016-04-05
PT2515889E (pt) 2015-03-20
CL2012001695A1 (es) 2013-03-08
EP2515889B1 (en) 2014-12-10
DK2515889T3 (en) 2015-03-02
US20120302522A1 (en) 2012-11-29
PL2515889T3 (pl) 2015-05-29
KR20120107970A (ko) 2012-10-04
EA022840B1 (ru) 2016-03-31
IL219552A (en) 2016-11-30
IL219552A0 (en) 2012-06-28
US10022449B2 (en) 2018-07-17
BR112012015202B1 (pt) 2020-12-08
KR101862415B1 (ko) 2018-05-29
CA2779532A1 (en) 2011-06-30
WO2011076367A3 (en) 2011-09-01
JP5902628B2 (ja) 2016-04-13
WO2011076367A2 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
EA201290373A1 (ru) Синергическая противовирусная композиция и ее применение
WO2012072713A3 (en) Lysine demethylase inhibitors such as cyclylcyclopropanamine derivatives for use in the treatment of diseases and disorders associated with flaviviridae
EA201491548A1 (ru) 2'-замещенные карбануклеозидные аналоги для противовирусного лечения
ECSP14013315A (es) Inhibidores de aplicación viral
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
ECSP099685A (es) Compuestos de azufre como inhibidores de la serina proteasa ns3 del virus de la hepatitis c
CL2013001436A1 (es) Composicion que comprende al menos una n-acetil-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado; y su uso para la prevencion y/o tratamiento de las condiciones de la piel y enfermedades de la piel.
CL2012002489A1 (es) Compuestos derivados de sililo nafto-imidazol; composición farmacéutica; y su uso para prevenir o tratar una infección por el virus de la hepatitis c.
CL2012001959A1 (es) Compuestos derivados del acido tiofeno-2-carboxilico, inhibidores de virus flaviviridae; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral por flaviviridae.
BR112012019529A2 (pt) inibidores de d-nitrosoglutationa redutase
CL2013001471A1 (es) Composicion que comprende al menos una n-acetil-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado y un hidrolizado que comprende proteinas parcialmente y/o completamente hidrolizadas; y su uso para la prevencion y/o tratamiento de las condiciones de la piel y enfermedades de la piel.
PH12015502230A1 (en) Novel viral replication inhibitors
UA108072C2 (uk) Засіб для профілактики і лікування високопатогенних інфекційних захворювань
UY32457A (es) Vacuna del virus del dengue inactivado
BR112012019351A2 (pt) composição de combinação, que inclui como ingredientes ativos l-carnitina ou propionil l-carnitina, para a prevenção ou tratamento de insuficiência venosa crônica.
PH12016500465A1 (en) Deoxynojirimycin derivatives and methods of their using
WO2012093234A3 (fr) Arabinogalactanes sulfates, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
ES2524385R1 (es) Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento y la prevención de enfermedades causadas por el VIH
EA201791525A3 (ru) Соединения для лечения блокады ремиелинизации при заболеваниях, связанных с экспрессией белка оболочки herv-w
BR112013009185A2 (pt) uso de mexiprostil no tratamento de doença inflamatória intestinal e/ou de síndrome do intestino irritável.
WO2009152519A3 (en) Novel antiviral peptides against influenza virus
EA201490963A1 (ru) Новые производные гемина с антибактериальной и противовирусной активностью
WO2010128016A3 (en) Par2 agonists for use in the treatment or prevention of influenza virus type a infections
EA201370058A1 (ru) Средство против вируса гриппа b
EA201370057A1 (ru) Средство против вируса гриппа b